CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenues | $ 36,882 | $ 58,041 | $ 71,201 | $ 114,476 | ||
| Costs and Expenses [Abstract] | ||||||
| Partner Share and other third-party costs | 15,614 | 26,721 | 30,211 | 55,825 | ||
| Delivery costs | 2,648 | 5,356 | 5,229 | 11,142 | ||
| Sales and marketing expense | 6,605 | 8,943 | 13,366 | 19,324 | ||
| Research and development expense | 5,540 | 9,867 | 11,970 | 20,145 | ||
| General and administrative expense | 7,855 | 12,238 | 16,136 | 25,181 | ||
| Change in contingent consideration | 0 | 42 | 0 | 102 | ||
| Loss (gain) on divestiture | 0 | 200 | 0 | (5,150) | ||
| Depreciation and amortization expense | 4,061 | 4,243 | 8,004 | 8,591 | ||
| Total costs and expenses | 42,323 | 67,610 | 84,916 | 135,160 | ||
| Operating loss | (5,441) | (9,569) | (13,715) | (20,684) | ||
| Other (expense) income: | ||||||
| Interest expense, net | (2,281) | (1,943) | (4,814) | (3,773) | ||
| Loss on investments | (1,102) | 0 | (2,387) | 0 | ||
| Foreign currency gain (loss) | 165 | 5,449 | (1,541) | 8,076 | ||
| Total other (expense) income | (3,218) | 3,506 | (8,742) | 4,303 | ||
| Loss before income taxes from continuing operations | (8,659) | (6,063) | (22,457) | (16,381) | ||
| Income tax benefit | 0 | 0 | 0 | 0 | ||
| Loss from continuing operations | (8,659) | (6,063) | (22,457) | (16,381) | ||
| (Loss) income from discontinued operations | (6,217) | (3,220) | 3,101 | (6,184) | ||
| Net loss | $ (14,876) | $ (9,283) | $ (19,356) | $ (22,565) | ||
| Net (loss) income per share, basic and diluted(1): | ||||||
| Continuing operations, basic (in dollars per share) | [1] | $ (1.50) | $ (1.15) | $ (3.99) | $ (3.13) | |
| Continuing operations, diluted (in dollars per share) | [1] | (1.50) | (1.15) | (3.99) | (3.13) | |
| Discontinued operations, basic (in dollars per share) | [1] | (1.08) | (0.61) | 0.55 | (1.18) | |
| Discontinued operations, diluted (in dollars per share) | [1] | $ (1.08) | $ (0.61) | $ 0.55 | $ (1.18) | |
| Weighted-average common shares outstanding, basic (in shares) | 5,759,000 | 5,275,000 | 5,625,000 | 5,230,000 | ||
| Weighted-average common shares outstanding, diluted (in shares) | 5,759,000 | 5,275,000 | 5,625,000 | 5,230,000 | ||
| ||||||
| X | ||||||||||
- Definition Change In Fair Value Of Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition Costs to deliver ad campaigns No definition available.
|
| X | ||||||||||
- Definition Financial Institution Share And Other Third-Party Costs No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|